The website and its content are not intended to be viewed and used by French & UK healthcare professionals

Symposia & Webinars

Is it realistic to OPTIMIZE guideline-recommended HF therapies?

 

The presentation starts with the objectives of the ESC guideline, and an overview of the current situation in UK for patients discharges with HFrEF.

In this real-world setting, greater optimization of guideline-directed therapies is associated with better outcomes. HF therapies are often not optimized before, but after worsening events:

  • Heart failure care remains sub-optimal for MANY patients; drug dosage is low and remains low.
  • Hospitalization is a key opportunity to optimize therapy and help educate patients and their families.

For the optimization of therapy, Martin Cowie shows a program to improve patient outcomes both during and after hospitalization, with 3 specific steps.

In this context he presents the PRIME_HF study: ivabradine initiation prior to discharge among stabilized HF patients increased ivabradine use at 6 months follow-up.

He also speaks about obstacles to implementation of the optimize heart failure care program and factors associated with effective implementation of the optimize heart failure care program:

  • Every contact must be used after hospitalization
  • A local champion is essential, leading the team
  • Success does not come overnight – try and try again

This video is part of the session “Emerging data in Heart Failure: are we doing enough to improve patients’ survival and quality of life?” held virtually at HFA Discovery 2020, with Professors Martin Cowie, Michael Böhm and Jian Zhang.

View also the other parts of the congress session: